Covid-19 roundup: EU calls on WTO mem­bers to ex­pand vac­cine and treat­ment man­u­fac­tur­ing; US re­moves DPA pri­or­i­ty rat­ings for As­traZeneca, J&J and Sanofi

The EU isn’t back­ing the US in its push to tem­porar­i­ly waive IP pro­tec­tions around Covid-19 vac­cines, but on Fri­day, the EU sub­mit­ted a new pro­pos­al to World Trade Or­ga­ni­za­tion mem­bers, seek­ing to lim­it the use of ex­port re­stric­tions and keep sup­ply chains open.

“Vac­cine-pro­duc­ing coun­tries should be ready to ex­port a fair share of their do­mes­tic pro­duc­tion,” the Eu­ro­pean Com­mis­sion said in a state­ment. “Sup­ply chains are high­ly in­ter­con­nect­ed and should not be dis­rupt­ed.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER